Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate.

ABSTRACT:

Objective

To investigate the frequency of remaining pain in early rheumatoid arthritis (RA) after 3 months of treatment with methotrexate as the only disease modifying antirheumatic drug, with a special focus on patients with a good clinical response.

Methods

The study base was cases reported to a population-based early RA cohort who had followup data from the Swedish Rheumatology Quality Register (n = 1,241). The Disease Activity Score in 28 joints European League Against Rheumatism (EULAR) response criteria were used to evaluate clinical response to treatment as good, moderate, and no response. The primary end point was remaining pain at the 3-months followup visit, defined as pain >20 mm on a 100-mm visual analog scale (VAS).

Results

Remaining pain in spite of a EU

SUBMITTER: Altawil R 

PROVIDER: S-EPMC5129578 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature